Tan Huiwen, Yu Kai, Yu Yerong, An Zhengmei, Li Jianwei
Department of Endocrinology and Metabolism.
Centre of Pituitary Adenoma and Related Diseases, West China Hospital, Sichuan University, Chengdu, China.
Medicine (Baltimore). 2019 Jan;98(2):e13853. doi: 10.1097/MD.0000000000013853.
Langerhans cell histiocytosis (LCH) is characterized by clonal proliferation of immature dendritic cells, mainly affects children. LCH in adult sellar region is extremely rare. In literature, optimal treatments remain unclear and only a few cases of LCH were treated using surgery. Here, we present a rare case of isolated hypothalamic-pituitary LHC in female adult. We focused on elucidating the clinical manifestations and immunohistochemical features of LCH, and exploring the proper treatment in adults.
A 50-year-old woman was admitted to our hospital, presenting with polydipsia and polyuria for over 3 months.
Radiological studies revealed lesions (0.5 × 0.9 × 0.4 cm) on posterior pituitary and enlarged pituitary stalk, which was moderately enhanced on contrast magnetic resonance imaging (MRI) of sellar region. In biopsy, pathological examination of Langerhans cells were observed with positive S-100 protein and Ki-67 antigen markers, findings were sufficient to establish a diagnosis of central nervous system (CNS) LCH.
The patient with LCH restricted in the sellar region received both surgery and chemotherapy. Gamma knife radiosurgery was performed after diagnosed as central diabetes insipidus (CDI) induced by pituitary lesion. And tumorectomy was performed 5 years later. However, in the latest MRI in 2017, the nodular shadow became larger (about 1.4 cm), chemotherapy and further systemic therapy were given.
At 12-month follow-up, no local reoccurrence was noticed.
For LCH, though difficult to be diagnosed and none defined standard therapeutic approach to adults, surgery should be considered if there are neurological symptoms or histological diagnosis. The present study showed that some manifestations can be meaningful when central nervous system (CNS) is involved. For complex diseases in the sellar region, multi-disciplinary team (MDT) model of diagnosis and treatment should be helpful for better clinical efficacy.
朗格汉斯细胞组织细胞增多症(LCH)的特征是未成熟树突状细胞的克隆性增殖,主要影响儿童。成人蝶鞍区LCH极为罕见。在文献中,最佳治疗方法仍不明确,仅有少数LCH病例采用手术治疗。在此,我们报告一例成年女性孤立性下丘脑 - 垂体LCH的罕见病例。我们着重阐明LCH的临床表现和免疫组化特征,并探索成人的合适治疗方法。
一名50岁女性因多饮多尿3个多月入住我院。
影像学检查显示垂体后叶有病变(0.5×0.9×0.4厘米),垂体柄增粗,蝶鞍区对比磁共振成像(MRI)显示病变呈中度强化。活检时观察到朗格汉斯细胞的病理检查结果,S - 100蛋白和Ki - 67抗原标记呈阳性,这些发现足以确诊中枢神经系统(CNS)LCH。
该蝶鞍区局限性LCH患者接受了手术和化疗。在被诊断为垂体病变导致中枢性尿崩症(CDI)后进行了伽玛刀放射外科治疗。5年后进行了肿瘤切除术。然而,在2017年的最新MRI检查中,结节状阴影变大(约1.4厘米),于是给予了化疗及进一步的全身治疗。
在12个月的随访中,未发现局部复发。
对于LCH而言,尽管诊断困难且尚无针对成人的明确标准治疗方法,但如果存在神经症状或组织学诊断,应考虑手术治疗。本研究表明,当累及中枢神经系统(CNS)时,一些表现可能具有重要意义。对于蝶鞍区的复杂疾病,多学科团队(MDT)诊疗模式有助于提高临床疗效。